Empagliflozin 25mg / Linagliptin 5mg tablets
- SNOMED code
37280511000001103- Active compound
- Empagliflozin + Linagliptin
- Preferred name basis
- Other
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Linagliptin
— 5 mg
based on ingredient substance
Empagliflozin — 25 mg based on ingredient substance - Form & Route
- tablet.oral
Oral tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Glyxambi 25mg/5mg tablets (Boehringer Ingelheim Ltd)
Glyxambi 25mg/5mg tablets
- SNOMED code
37225511000001102- Supplier
- Boehringer Ingelheim Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Glyxambi 25mg/5mg tablets (Boehringer Ingelheim Ltd) 28 tablet 4 x 7 tablets37225611000001103 ref. pack | 💯 Available Legal category: POM | 5012816099258End: 5012816099319 | NHS Indicative Price £55.88 | — |
| — |
Reference packs
Empagliflozin 25mg / Linagliptin 5mg tablets 28 tablet
- SNOMED code
37225411000001101- Quantity and unit
- 28 tablet
- Drug Tariff
payment category: Part VIIIA Category C
£55.88- Packs